Currently, used AAA models include infrarenal aortic infusion of porcine pancreatic elastase (PPE), periaortic calcium chloride painting, subcutaneous infusion of angiotensin II (Ang II), and genetically or pharmacologically modified animals for transforming growth factor-β and its receptors [4–7]. Here, AGT is linked to triple-A syndrome.